Research Institute: Diamantina Institute, University of Queensland
Amount granted: $1 million
Year granted: 1999
The ACRF grant was awarded as initial seed funding for the development of a vaccine to prevent cervical cancer.
As cervical cancer is entirely caused by persistent papillomavirus infection, it seems likely that cervical cancer should now be preventable through vaccination. This vaccine is very important as five million women worldwide will develop cervical cancer as a result of an existing papillomavirus infection.
Further Key Outcomes:
This update was provided in 2002 by Director, Professor Ian Frazer:
What your donations have achieved
Cervical cancer vaccine
We gave initial seed funding to Professor Ian Frazer’s research into the cervical cancer (HPV). Over 150 million doses of vaccine have been delivered worldwide to date.
The pill that melts away cancer
Our long term support of cancer research at WEHI has led to a treatment that melts away certain advanced forms of chronic lymphocytic leukaemia. It has been approved for clinical use in the US, European Union and Australia and is being trialled for other types of cancer.
Personalised cancer diagnosis
In 2015, we awarded $10 million seed funding to an ambitious cancer proteome project that aims to provide each cancer patient a personalised treatment plan within 36 hours. This will improve treatment outcomes and help avoid unnecessary treatments.
Zero childhood cancer
We are one of the founding partners of the initiative that will tackle the most serious cases of infant, childhood and adolescent cancer in Australia. It is a key step towards the program vision of one day helping to cure 100% of children with cancer.